Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Toxicology Letters
|
March 18, 2017
In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks
Lea Wagmann, Simon D Brandt, Pierce V Kavanagh, et al.
Metabolites
|
August 26, 2021
In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity
Matthias J Richter, Lea Wagmann, Tanja M Gampfer, et al.
Talanta
|
March 24, 2020
Development and application of a strategy for analyzing eight biomarkers in human urine to verify toxic mushroom or ricinus communis ingestions by means of hydrophilic interaction LC coupled to HRMS/MS
Thomas P Bambauer, Lea Wagmann, Hans H Maurer, et al.
Drug Testing and Analysis
|
August 20, 2019
Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein binding
Tanja M Gampfer, Lilian H J Richter, Jan Schäper, et al.
Archives of Toxicology
|
May 20, 2026
Human serum-supplemented cell culture conditions improve xenobiotic metabolism in hepatoma cell lines HepG2 and Huh7
Matthias D Kroesen, Lea Wagmann, Anna-Lena Gehl, et al.
Toxicology
|
July 16, 2022
A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay - Exemplified for nine compounds
Tanja M Gampfer, Lea Wagmann, Benedikt Pulver, et al.
Analytica Chimica Acta
|
August 25, 2024
Studying drug excretion into exhaled breath aerosol - A workflow based on an impaction sampling device and LC-HRMS/MS analysis
Juel Maalouli Schaar, Michael Kunz, Lea Wagmann, et al.
Drug Testing and Analysis
|
July 12, 2018
In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases
Madeleine Pettersson Bergstrand, Lilian H J Richter, Hans H Maurer, et al.
Talanta
|
January 1, 2026
Capillary blood microsampling and LC-Orbitrap analysis for adherence monitoring of cardiovascular drugs: method development, cross-validation, and patient proof-of-concept using VAMS and Capitainer-B
Diana Kretschmer, Mert Tokcan, Philipp Markwirth, et al.
Journal of Analytical Toxicology
|
February 6, 2020
Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl
Tanja M Gampfer, Lea Wagmann, Matthias J Richter, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Toxicology Letters
|
March 18, 2017
In vitro monoamine oxidase inhibition potential of alpha-methyltryptamine analog new psychoactive substances for assessing possible toxic risks
Lea Wagmann, Simon D Brandt, Pierce V Kavanagh, et al.
Metabolites
|
August 26, 2021
In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity
Matthias J Richter, Lea Wagmann, Tanja M Gampfer, et al.
Talanta
|
March 24, 2020
Development and application of a strategy for analyzing eight biomarkers in human urine to verify toxic mushroom or ricinus communis ingestions by means of hydrophilic interaction LC coupled to HRMS/MS
Thomas P Bambauer, Lea Wagmann, Hans H Maurer, et al.
Drug Testing and Analysis
|
August 20, 2019
Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein binding
Tanja M Gampfer, Lilian H J Richter, Jan Schäper, et al.
Archives of Toxicology
|
May 20, 2026
Human serum-supplemented cell culture conditions improve xenobiotic metabolism in hepatoma cell lines HepG2 and Huh7
Matthias D Kroesen, Lea Wagmann, Anna-Lena Gehl, et al.
Toxicology
|
July 16, 2022
A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay - Exemplified for nine compounds
Tanja M Gampfer, Lea Wagmann, Benedikt Pulver, et al.
Analytica Chimica Acta
|
August 25, 2024
Studying drug excretion into exhaled breath aerosol - A workflow based on an impaction sampling device and LC-HRMS/MS analysis
Juel Maalouli Schaar, Michael Kunz, Lea Wagmann, et al.
Drug Testing and Analysis
|
July 12, 2018
In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases
Madeleine Pettersson Bergstrand, Lilian H J Richter, Hans H Maurer, et al.
Talanta
|
January 1, 2026
Capillary blood microsampling and LC-Orbitrap analysis for adherence monitoring of cardiovascular drugs: method development, cross-validation, and patient proof-of-concept using VAMS and Capitainer-B
Diana Kretschmer, Mert Tokcan, Philipp Markwirth, et al.
Journal of Analytical Toxicology
|
February 6, 2020
Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl
Tanja M Gampfer, Lea Wagmann, Matthias J Richter, et al.
Page
of 8